- Home
- TECH vs ESTA Comparison
TECH vs ESTA Comparison
Compare TECH & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- ESTA
- Stock Information
- Founded
- TECH 1976
- ESTA 2004
- Country
- TECH United States
- ESTA Costa Rica
- Employees
- TECH N/A
- ESTA N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- ESTA Industrial Specialties
- Sector
- TECH Health Care
- ESTA Health Care
- Exchange
- TECH Nasdaq
- ESTA Nasdaq
- Market Cap
- TECH 8.0B
- ESTA N/A
- IPO Year
- TECH 1989
- ESTA 2018
- Fundamental
- Price
- TECH $48.10
- ESTA $31.45
- Analyst Decision
- TECH Buy
- ESTA Buy
- Analyst Count
- TECH 9
- ESTA 7
- Target Price
- TECH $81.25
- ESTA $59.17
- AVG Volume (30 Days)
- TECH 2.2M
- ESTA 675.6K
- Earning Date
- TECH 05-07-2025
- ESTA 05-07-2025
- Dividend Yield
- TECH 0.63%
- ESTA N/A
- EPS Growth
- TECH N/A
- ESTA N/A
- EPS
- TECH 0.98
- ESTA N/A
- Revenue
- TECH $1,196,016,000.00
- ESTA $166,025,000.00
- Revenue This Year
- TECH $8.19
- ESTA $27.37
- Revenue Next Year
- TECH $8.85
- ESTA $24.66
- P/E Ratio
- TECH $52.13
- ESTA N/A
- Revenue Growth
- TECH 4.46
- ESTA 0.53
- 52 Week Low
- TECH $46.44
- ESTA $26.56
- 52 Week High
- TECH $85.57
- ESTA $60.12
- Technical
- Relative Strength Index (RSI)
- TECH 33.97
- ESTA 43.12
- Support Level
- TECH $46.44
- ESTA $29.17
- Resistance Level
- TECH $53.00
- ESTA $32.52
- Average True Range (ATR)
- TECH 3.30
- ESTA 3.85
- MACD
- TECH -0.27
- ESTA -0.49
- Stochastic Oscillator
- TECH 13.00
- ESTA 30.79
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.